Role of PET/CT for precision medicine in lung cancer: Perspective of the Society of Nuclear Medicine and Molecular Imaging

Bennett S. Greenspan

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This article discusses the role of PET/CT in contributing to precision medicine in lung cancer, and provides the perspective of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) on this process. The mission and vision of SNMMI are listed, along with the guidance provided by SNMMI to promote best practice in precision medicine. Basic principles of PET/CT are presented. An overview of the use of PET/CT imaging in lung cancer is discussed. In lung cancer patients, PET/CT is vitally important for optimal patient management. PET/CT is essential in determining staging and re-staging of disease, detecting recurrent or residual disease, evaluating response to therapy, and providing prognostic information. PET/CT is also critically important in radiation therapy planning by determining the extent of active disease, including an assessment of functional tumor volume. The current approach in tumor imaging is a significant advance over conventional imaging. However, recent advances suggest that therapeutic response criteria in the near future will be based on metabolic characteristics and will include the evaluation of biologic characteristics of tumors to further enhance the effectiveness of precision medicine in lung cancer, producing improved patient outcomes with less morbidity.

Original languageEnglish (US)
Pages (from-to)617-620
Number of pages4
JournalTranslational Lung Cancer Research
Volume6
Issue number6
DOIs
StatePublished - Dec 1 2017

Fingerprint

Precision Medicine
Molecular Imaging
Lung Neoplasms
Nuclear Medicine
Tumor Burden
Practice Guidelines
Neoplasms
Radiotherapy
Morbidity
Therapeutics

Keywords

  • Lung cancer
  • PET/CT
  • Precision medicine
  • Society of Nuclear Medicine and Molecular Imaging (SNMMI)
  • Tumor imaging

ASJC Scopus subject areas

  • Oncology

Cite this

Role of PET/CT for precision medicine in lung cancer : Perspective of the Society of Nuclear Medicine and Molecular Imaging. / Greenspan, Bennett S.

In: Translational Lung Cancer Research, Vol. 6, No. 6, 01.12.2017, p. 617-620.

Research output: Contribution to journalArticle

@article{5ea05cad279148419efdac7ef12db2e4,
title = "Role of PET/CT for precision medicine in lung cancer: Perspective of the Society of Nuclear Medicine and Molecular Imaging",
abstract = "This article discusses the role of PET/CT in contributing to precision medicine in lung cancer, and provides the perspective of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) on this process. The mission and vision of SNMMI are listed, along with the guidance provided by SNMMI to promote best practice in precision medicine. Basic principles of PET/CT are presented. An overview of the use of PET/CT imaging in lung cancer is discussed. In lung cancer patients, PET/CT is vitally important for optimal patient management. PET/CT is essential in determining staging and re-staging of disease, detecting recurrent or residual disease, evaluating response to therapy, and providing prognostic information. PET/CT is also critically important in radiation therapy planning by determining the extent of active disease, including an assessment of functional tumor volume. The current approach in tumor imaging is a significant advance over conventional imaging. However, recent advances suggest that therapeutic response criteria in the near future will be based on metabolic characteristics and will include the evaluation of biologic characteristics of tumors to further enhance the effectiveness of precision medicine in lung cancer, producing improved patient outcomes with less morbidity.",
keywords = "Lung cancer, PET/CT, Precision medicine, Society of Nuclear Medicine and Molecular Imaging (SNMMI), Tumor imaging",
author = "Greenspan, {Bennett S.}",
year = "2017",
month = "12",
day = "1",
doi = "10.21037/tlcr.2017.09.01",
language = "English (US)",
volume = "6",
pages = "617--620",
journal = "Translational Lung Cancer Research",
issn = "2226-4477",
publisher = "Society for Translational Medicine (STM)",
number = "6",

}

TY - JOUR

T1 - Role of PET/CT for precision medicine in lung cancer

T2 - Perspective of the Society of Nuclear Medicine and Molecular Imaging

AU - Greenspan, Bennett S.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - This article discusses the role of PET/CT in contributing to precision medicine in lung cancer, and provides the perspective of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) on this process. The mission and vision of SNMMI are listed, along with the guidance provided by SNMMI to promote best practice in precision medicine. Basic principles of PET/CT are presented. An overview of the use of PET/CT imaging in lung cancer is discussed. In lung cancer patients, PET/CT is vitally important for optimal patient management. PET/CT is essential in determining staging and re-staging of disease, detecting recurrent or residual disease, evaluating response to therapy, and providing prognostic information. PET/CT is also critically important in radiation therapy planning by determining the extent of active disease, including an assessment of functional tumor volume. The current approach in tumor imaging is a significant advance over conventional imaging. However, recent advances suggest that therapeutic response criteria in the near future will be based on metabolic characteristics and will include the evaluation of biologic characteristics of tumors to further enhance the effectiveness of precision medicine in lung cancer, producing improved patient outcomes with less morbidity.

AB - This article discusses the role of PET/CT in contributing to precision medicine in lung cancer, and provides the perspective of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) on this process. The mission and vision of SNMMI are listed, along with the guidance provided by SNMMI to promote best practice in precision medicine. Basic principles of PET/CT are presented. An overview of the use of PET/CT imaging in lung cancer is discussed. In lung cancer patients, PET/CT is vitally important for optimal patient management. PET/CT is essential in determining staging and re-staging of disease, detecting recurrent or residual disease, evaluating response to therapy, and providing prognostic information. PET/CT is also critically important in radiation therapy planning by determining the extent of active disease, including an assessment of functional tumor volume. The current approach in tumor imaging is a significant advance over conventional imaging. However, recent advances suggest that therapeutic response criteria in the near future will be based on metabolic characteristics and will include the evaluation of biologic characteristics of tumors to further enhance the effectiveness of precision medicine in lung cancer, producing improved patient outcomes with less morbidity.

KW - Lung cancer

KW - PET/CT

KW - Precision medicine

KW - Society of Nuclear Medicine and Molecular Imaging (SNMMI)

KW - Tumor imaging

UR - http://www.scopus.com/inward/record.url?scp=85031318313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031318313&partnerID=8YFLogxK

U2 - 10.21037/tlcr.2017.09.01

DO - 10.21037/tlcr.2017.09.01

M3 - Article

AN - SCOPUS:85031318313

VL - 6

SP - 617

EP - 620

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

SN - 2226-4477

IS - 6

ER -